Free Trial

Reviva Pharmaceuticals (RVPHW) Competitors

Reviva Pharmaceuticals logo
$0.03 +0.00 (+4.48%)
As of 07/25/2025 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RVPHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying Reviva Pharmaceuticals stock or one of its competitors? The main competitors of Reviva Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Reviva Pharmaceuticals vs. Its Competitors

Reviva Pharmaceuticals (NASDAQ:RVPHW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Reviva Pharmaceuticals and Reviva Pharmaceuticals both had 1 articles in the media. Reviva Pharmaceuticals' average media sentiment score of 1.89 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Reviva Pharmaceuticals Very Positive
180 Life Sciences Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reviva PharmaceuticalsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Reviva PharmaceuticalsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Reviva Pharmaceuticals and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Reviva Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVPHW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVPHW vs. The Competition

MetricReviva PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$136.79M$5.69B$9.50B
Dividend YieldN/A3.74%4.58%4.01%
P/E RatioN/A3.7528.1020.05
Price / SalesN/A4,471.55432.4490.07
Price / CashN/A13.1936.2258.56
Price / BookN/A42.328.665.87
Net IncomeN/A-$90.99M$3.25B$258.55M
7 Day PerformanceN/A4.83%4.23%3.74%
1 Month PerformanceN/A8.36%10.52%11.75%
1 Year PerformanceN/A195.89%34.41%18.03%

Reviva Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVPHW
Reviva Pharmaceuticals
N/A$0.03
+4.5%
N/A-84.8%$0.00N/A0.005Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-9.5%
N/A+22.2%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.16
-2.0%
N/A+95.0%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.75
-10.7%
N/A-0.7%$0.00$585.60M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-2.8%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
+0.7%
N/A-96.8%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.06
+15.1%
N/A-78.1%$0.00N/A0.008Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.2%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:RVPHW) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners